Immunotherapy checkpoint inhibitor-combination therapy versus chemotherapy alone among Chinese population in cholangiocarcinoma treatment: a systematic review and meta-analysis.
APA
Shi L, Du W, et al. (2026). Immunotherapy checkpoint inhibitor-combination therapy versus chemotherapy alone among Chinese population in cholangiocarcinoma treatment: a systematic review and meta-analysis.. European journal of clinical pharmacology, 82(2), 29. https://doi.org/10.1007/s00228-025-03948-x
MLA
Shi L, et al.. "Immunotherapy checkpoint inhibitor-combination therapy versus chemotherapy alone among Chinese population in cholangiocarcinoma treatment: a systematic review and meta-analysis.." European journal of clinical pharmacology, vol. 82, no. 2, 2026, pp. 29.
PMID
41546709
같은 제1저자의 인용 많은 논문 (5)
- Severe bone resorption in expanded polytetrafluoroethylene chin augmentation.
- Next-generation sequencing for DLBCL patients with early failure after frontline R-CHOP chemo-immunotherapy.
- [Clinical efficacy analysis of seven pediatric patients with Acute myeloid leukemia and the t(16;21)(p11;q22) FUS::ERG fusion gene].
- Halofuginone exerts broad-spectrum cytotoxic effects by regulating p-eIF2α-S100A8/A9-calcium signaling, inhibiting global protein synthesis, and reversing the resistance of idarubicin in acute myeloid leukemia.
- NAD precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL.